tiprankstipranks
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market

Evofem Biosciences (EVFM) Balance Sheet

1,212 Followers

Evofem Biosciences Balance Sheet

Evofem Biosciences's total assets for Q3 2023 were $13.32M, a decrease of -5.34% from the previous quarter. EVFM total liabilities were $67.88M for the fiscal quarter, a -2.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 25.16M$ 42.51M$ 109.97M$ 28.30M$ 4.01M
Total Liabilities
$ 96.96M$ 142.09M$ 108.62M$ 12.66M$ 27.37M
Total Equity Gross Minority
$ -71.80M$ -104.31M$ 1.35M$ 15.64M$ -23.36M
Total Capitalization
$ -71.80M$ -104.31M$ 26.56M$ 15.64M$ -23.36M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 8.32M$ 197.00K$ 0.00
Currency in USD

Evofem Biosciences Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis